Generated by DeepSeek V3.2| doxycycline | |
|---|---|
| IUPAC name | (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide |
| Tradename | Vibramycin, others |
| Drugs.com | Monograph |
| MedlinePlus | a682063 |
| Routes of administration | By mouth, intravenous |
| Bioavailability | ~100% |
| Protein bound | 80–90% |
| Metabolism | Liver |
| Elimination half-life | 18–22 hours |
| Excretion | Urine (~40%), feces |
doxycycline. Doxycycline is a broad-spectrum tetracycline antibiotic used to treat a wide array of bacterial infections and certain parasitic diseases. It is commonly prescribed for conditions like acne, rosacea, Lyme disease, and malaria prophylaxis. The drug works by inhibiting protein synthesis in susceptible bacteria, effectively halting their growth and replication.
Doxycycline is indicated for infections caused by organisms such as Rickettsia, which causes Rocky Mountain spotted fever, and Chlamydia trachomatis, the agent of chlamydia infection. It is a first-line agent for treating Lyme disease, particularly for early-stage manifestations like erythema migrans. The World Health Organization includes it on its List of Essential Medicines for its role in managing epidemic typhus and combating Bacillus anthracis in cases of anthrax exposure. Furthermore, it is utilized in the management of chronic conditions like acne vulgaris and periodontitis, and for prophylaxis against malaria in regions with Plasmodium falciparum resistance to other drugs like chloroquine.
Common adverse effects involve the gastrointestinal tract, including nausea, vomiting, and diarrhea. A significant concern is photosensitivity, increasing the risk of severe sunburn upon exposure to ultraviolet light. Doxycycline use is contraindicated in children under eight years of age and during pregnancy due to the risk of permanent tooth discoloration and impaired bone development, as noted by the U.S. Food and Drug Administration. Rare but serious side effects can include benign intracranial hypertension, severe allergic reactions, and Clostridioides difficile-associated diarrhea. Concomitant use with drugs like warfarin may potentiate anticoagulant effects, requiring careful monitoring.
Doxycycline exerts its bacteriostatic effect by binding reversibly to the 30S ribosomal subunit, thereby inhibiting the binding of aminoacyl-tRNA to the mRNA-ribosome complex during protein synthesis. It is well-absorbed orally, with bioavailability nearly complete, and its absorption is only minimally affected by calcium or dairy products, unlike earlier tetracyclines. The drug is highly lipophilic, allowing for excellent tissue penetration, including into the cerebrospinal fluid and prostate. Metabolism occurs in the liver, and it is excreted in both urine and bile; its long elimination half-life permits once- or twice-daily dosing. Resistance mechanisms, often mediated by genes on plasmid or transposon elements, include efflux pumps and ribosomal protection proteins.
Doxycycline was first synthesized in the early 1960s by researchers at Pfizer through the chemical modification of oxytetracycline, a natural product derived from Streptomyces rimosus. Its development, led by scientists like Lloyd H. Conover, was part of a broader effort by the pharmaceutical industry to create longer-acting, better-tolerated tetracycline analogs. It received approval from the U.S. Food and Drug Administration in 1967 and was marketed under the brand name Vibramycin. Its utility expanded significantly during the Vietnam War for the prevention of scrub typhus among military personnel. Subsequent decades saw its role solidify in protocols from the Centers for Disease Control and Prevention for treating sexually transmitted infections and in guidelines from the Infectious Diseases Society of America for Lyme disease.
Doxycycline is available globally as a generic medication and is considered cost-effective by organizations like the World Health Organization. It has been employed in large-scale public health initiatives, such as mass drug administration for trachoma control in endemic regions of Africa and Asia under the auspices of the WHO Alliance for the Global Elimination of Trachoma. In the United States, it is a schedule IV controlled substance only in its formulation as an anti-malarial, due to regulations by the Drug Enforcement Administration. Cultural perceptions of the drug are generally positive due to its broad utility, though concerns about antibiotic resistance have prompted stewardship campaigns by bodies like the European Centre for Disease Prevention and Control. Its use in veterinary medicine for animals like dogs and cats is also widespread.
Category:World Health Organization essential medicines Category:Tetracycline antibiotics Category:Antibiotics